Abstract
Substance use disorders and eating disorders can lead to unhealthy eating and malnutrition that is associated with varying degrees of medical morbidity and increased risk of death. Vitamin and mineral deficiencies are most common in patients with anorexia nervosa, bulimia nervosa, and alcohol use disorders but can be seen in other substance use disorders as well. These disorders may share some underlying pathophysiology and can co-occur, which further increases the risk of malnutrition. The specific nutritional deficits in eating disorders and substance use disorders, their clinical (especially neurological) manifestations, how commonly they occur, and their mechanisms of action will be discussed in this chapter.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Eating disorders
- Substance use disorders
- Nutritional deficiency
- Alcohol use disorders
- Anorexia nervosa
- Binge eating disorder
- Bulimia nervosa
1 Introduction
The importance of nutrition for healthy living was discussed as early as the fifth century when Hippocrates suggested that many health problems could be prevented or alleviated with healthy diet (and exercise) (Simopoulos, 2001). Nutrition refers to the supply of foods or supplements for the growth and maintenance of a living organism. There are six major classes of nutrients. These include carbohydrates, proteins, fats, water, vitamins, and minerals. Over the centuries, specific nutritional deficiencies have been shown to carry deleterious health effects. One of the earliest discoveries was made by Dr. James Lind who in 1747 treated scurvy among British sailors and seafarers with lime juice. In the early 1930s it was found that scurvy is a disease due to deficit of the essential nutrient vitamin C. Similarly, Japanese sailors whose diets consisted primarily of white rice developed beriberi (a constellation of neurological and cardiac deficits) from which they often died. This condition was later found to be due to thiamine deficiency. Since then, numerous medical disorders have been linked to malnutrition or specific nutrient deficiencies. Many governments throughout the world have set forth specific guidelines for food consumption and daily requirements of vitamins and minerals.
There are a number of psychiatric conditions that predispose people to develop malnutrition, most commonly addiction to substances substance use disorders (SUD) or disordered eating from eating disorders (ED) anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED). Malnutrition can be seen in other psychiatric conditions such as schizophrenia when delusions are related to food intake (McCormick, Buchanan, Onwuameze, Pierson, & Paradiso, 2011) or in children with attention-deficit hyperactivity disorder when appetite is decreased from stimulant use (Davis et al., 2007; Schachter, King, Langford, & Moher, 2001). This chapter will primarily focus on the mechanisms of malnutrition and their sequelae occurring among individuals suffering with SUD and ED and especially when these two conditions co-occur.
2 Mechanisms and Clinical Manifestations of Malnutrition in SUD
The first descriptions of addiction to substances were found in Sumerian writings as early as 6,000 years BC (Davenport-Hines, 2003; Krikorian, 1975). SUD have become known today as a cluster of cognitive, behavioral, and psychological symptoms indicating that an individual continues using substances despite substance-related problems (American Psychiatric Association, 2013). The most recent version of the Diagnostic and Statistical Manual of Mental Illness (DSM-5) considers what was formerly indicated as substance abuse and dependence as a continuum of disorders involving the use of substances from mild to severe, according to the number of endorsed symptoms (American Psychiatric Association, 2013). The threshold for diagnosing mild substance use disorders is set at two symptoms (or criteria) from a list of 11. Craving is a symptom not present in the previous version of the Manual (i.e., a strong desire to use a substance). Problems with law enforcement are eliminated due to cultural considerations.
Malnutrition and nutritional deficiencies are common among people with SUD (Abd El Gawad, Hassan, Ghanem, Awad, & Ali, 2011; Gueguen et al., 2003; Islam, Hossain, Ahmed, & Ahsan, 2002; Saeland et al., 2008). SUD impact nutrition and diet in at least two ways (1) through reduced food intake and by the deleterious effects of the used substances on the body. It is plausible that combination effects may be multiplicative rather than simply additive. Perhaps because of the alteration in reward and impulse control pathways, people who suffer with SUD show poor decision-making in nutritional choices that can create a variety of deficiencies and/or excesses of certain nutrients. Diminished and/or poor nutritional choices may result in noxious effects on the body irrespective of the substance abused. With poor nutrition, the most common nutrients impacted are the vitamins and rare minerals that are supplied from fresh vegetables and fruits including vitamin A (e.g., carotene), B vitamins (thiamine, niacin, pantothenic acid, and biotin), vitamin C, vitamin E, folic acid, copper, potassium, manganese, magnesium, molybdenum, and selenium. Some drugs including cocaine, marijuana, amphetamine, and heroin may impact food intake by reducing appetite (Anglin, Burke, Perrochet, Stamper, & Dawud-Noursi, 2000; Mohs, Watson, & Leonard-Green, 1990). Some substances of abuse have been shown to be directly neurotoxic such as ecstasy, inhalants, hallucinogens, and methamphetamine (Ares-Santos, Granado, & Moratalla, 2013; Cairney et al., 2013; Capela et al., 2013; Cowan, Roberts, & Joers, 2008; Marona-Lewicka, Nichols, & Nichols, 2011; Takagi, Lubman, & Yucel, 2011). The specific nutritional impact of some of the more commonly used substances will be discussed in more detail below.
A nationwide study in 2008 showed that alcohol is the most commonly abused substance in the USA, followed by cannabis and methamphetamine abuse (Substance Abuse and Mental Health Services Administration, 2011). Excess use of this substance is known to cause deficiency of several vitamins and minerals through impaired absorption, metabolism, and utilization (Lieber, 2003; McClain, Barve, Barve, & Marsano, 2011; Strohle, Wolters, & Hahn, 2012). Alcohol can exert direct effects on metabolism or effects due to the progression of medical conditions associated with alcohol overuse (e.g., hepatitis and dilated cardiomyopathy). Impaired absorption is in the early stages secondary to the effects of alcohol to the gastric mucosa. In later stages of the illness, poor absorption develops due to gastritis secondary to cirrhosis and the relative venous stasis in the portal splanchnic district. Metabolism is generally altered in various degrees according to the severity of accompanying hepatic pathology. Vitamin deficiencies in alcohol use disorders (AUD) include vitamin A, vitamins of the B family (thiamine, riboflavin, niacin, pantothenic acid, pyridoxine, and cobalamin), folic acid, vitamin C, vitamin D, and vitamin E (Clugston & Blaner, 2012; Strohle et al., 2012). The mineral deficiencies associated with AUD include calcium, magnesium, and zinc (Devgun, Fiabane, Paterson, Zarembski, & Guthrie, 1981). These deficiencies are thought to play a role in some forms of dementia and depression as well as poor appetite (Coppen, 2005; Glick, 1990; Ramsey & Muskin, 2013; Rasmussen, Mortensen, & Jensen, 1989; Tiemeier et al., 2002). Men with AUD have been shown to have low levels of vitamin D and are at an increased risk of osteoporosis due to direct and indirect effects on bone remodeling and formation, which leads to increased risk for fractures (González-Reimers et al., 2011). Similarly, men with AUD may be at risk for bleeding problems secondary to vitamin K deficiency by disturbed absorption through the liver, which is often impaired from heavy alcohol use (Iber, Shamszad, Miller, & Jacob, 1986).
The most serious and life-threatening deficiency that occurs in AUD is a deficiency of B vitamins including thiamine and folic acid. These deficiencies are known to be associated with dementia (Goebels & Soyka, 2000). Wernicke’s encephalopathy and Korsakoff’s syndrome are severe life-threatening conditions that can occur in a thiamine-deficient state induced by poor nutrition often caused by severe alcoholism (Lough, 2012). There are times in which the lack of one B vitamin impairs the utilization of another. For example, folic acid cannot be utilized in the body in the absence of B12 and when deficient folic acid can mask vitamin B12 deficiency as well.
The impact of addiction to tetrahydrocannabinol (THC) in cannabis on nutrients has not been studied to the same extent as alcohol. Results from the third national health and nutrition examination survey showed higher cigarette-smoking rates and higher consumption of sodas and alcohol, including beer, among current cannabis users than among non-current cannabis users (Smit & Crespo, 2001). Cannabis users also consumed more sodium, fewer fruits, and more pork, cheese, and salty snacks, which resulted in lower serum carotenoid levels (i.e., vitamin A deficiency) (Smit & Crespo, 2001). Vitamin A deficiency can result in night blindness (complete blindness in severe deficiency), impaired immunity to infections, predisposition to cancer, and even birth defects. While cannabis can increase appetite in some people, several studies and two national surveys have found that active cannabis users (using at least three times a week) actually have a lower body mass index (BMI) than persons who do not use cannabis (Le Strat & Le Foll, 2011; Penner, Buettner, & Mittleman, 2013; Rodondi, Pletcher, Liu, Hulley, & Sidney, 2006). The studies revealed that smoking cannabis was also associated with a smaller waist circumference and lower insulin levels than those who do not use cannabis (Penner et al., 2013; Rodondi et al., 2006).
Illicit stimulant substances such as cocaine and amphetamine (methamphetamine) have been shown to decrease appetite when using and when withdrawing from substance (Walsh, Donny, Nuzzo, Umbricht, & Bigelow, 2010). Calorie and protein malnutrition has been found in people who use cocaine chronically (Santolaria-Fernández et al., 1995). Rodent models of cocaine addiction have also found that to cocaine continued use of the substance and neglect food (Sanchis-Segura, & Spanagel, 2006). Cocaine and methamphetamine have been found to be especially neurotoxic to dopaminergic neurons in the basal ganglia and hippocampus in animal models (Aksenov et al., 2006; Ares-Santos et al., 2013; Capela et al., 2013; Olsen, 1995) and have been linked to myocardial infarctions in humans (Galasko, 1997; Isner et al., 1986; Lange & Hillis, 2001). More data is needed to fully understand the specific nutritional deficiencies that occur with addiction to stimulant substances, but there appears to be at least indirect effects of poor appetite causing reduced consumption of nutritious food.
Poor appetite leading to poor intake of nutrients is also the likely cause of malnutrition in people primarily addicted to opiates (Meleger, Froude, & Walker, 2013; Morabia et al., 1989; Neale, Nettleton, Pickering, & Fischer, 2012). In a study of 149 people addicted to heroin 25 % were found to have hypovitaminemia, primarily of B vitamins, which are water soluble and are most vulnerable during poor intake of regular food (el-Nakah, Frank, Louria, Quinones, & Baker, 1979). Hyperkalemia (or increased blood potassium) has been reported in heroin addiction, while calcium deficiency has been reported in morphine abusers (Mohs et al., 1990). Hyperkalemia can lead to deadly arrhythmias, while calcium deficiency can cause altered bone metabolism and reduced trabecular bone mass resulting in osteoporosis (Katz & Norman, 2009; Roberts, Finch, Pullan, Bhagat, & Price, 2002).
In summary, common nutritional deficiencies associated with SUD occur early in the addiction process and continue as the illness progresses, poor consumption of a balanced diet is but one mechanism of malnutrition. There is evidence that the acute intoxicating effects and long-term craving of particular substances also impair insight and decision-making leading to poor self-care and malnutrition. There is also an association between chronic substance addiction and unemployment as well as homelessness (Johnson, Freels, Parsons, & Vangeest, 1997), which may contribute to a lack of access to nutritious food (Beharry, 2012; Rehm et al., 2009). Studies suggest that having a SUD increases the chances of being addicted to more than one substance (Aggrawal, 2001; Perkonigg, Lieb, & Wittchen, 1998), which may theoretically increase the chances of malnutrition. More studies are needed to fully understand all the deleterious effects of SUD on the body and brain to improve strategies for treatment and prevention.
3 Mechanisms and Clinical Manifestations of Malnutrition in ED
Disordered eating that leads to clinical or subclinical malnutrition of macronutrients (e.g., carbohydrates, proteins, fats) and/or micronutrients (e.g., vitamins, minerals, trace elements) is often present to varying degrees in people suffering from AN and can be seen in some patients with BN (Casper, Kirschner, Sandstead, Jacob, & Davis, 1980; Rock & Vasantharajan, 1995; Setnick, 2010; Winston, 2012). Typical nutritional problems that occur with BED include excessive intake of highly caloric foods that can lead to significant weight gain but will not be discussed in detail here (Raymond, Bartholome, Lee, Peterson, & Raatz, 2007; Schneider, 2003). There are a number of medical consequences of vitamin and mineral deficiencies as well as severe electrolyte disturbances that have been described in patients with AN and BN, which can occur in SUD as well, particularly AUD (see Table 8.1). The most life-threatening electrolyte abnormality is hypokalemia, which can lead to life-threatening arrhythmias and cardiac arrest in AN and BN (Hofland & Dardis, 1992; Winston, 2012). This condition develops primarily due to metabolic alkalosis from purging behaviors that include vomiting, laxative use, and/or diuretic use. Poor intake of calories and particularly of protein has been associated with liver damage, anemia, and neutropenia in AN (Sabel, Gaudiani, Statland, & Mehler, 2013; Tomita et al., 2013).
Patients suffering with AN are also at high risk of developing osteopenia or osteoporosis, conditions whose mechanisms are multifactorial including low estrogen and poor intake of calcium and/or vitamin D (Fonseca et al., 1988; Legroux-Gerot, Vignau, Collier, & Cortet, 2005; Misra et al., 2004). One study in Japan found that 40 % of adolescent patients with AN met criteria for osteoporosis and that an earlier onset of AN increase the risk, since adolescence is such an important time for acquisition of peak bone mass development (Maesaka & Hasegawa, 2003). Vitamin D is a fat-soluble vitamin responsible for enhancing intestinal absorption of calcium and phosphate. It can be synthesized in the skin and is also absorbed in the gastrointestinal tract primarily from dairy products but is converted into its biologically active form through the liver and kidneys, and thus the presence of liver or kidney damage in AUD and/or AN can contribute to deficiency of this vitamin (De Caprio et al., 2006). Excess vitamin D taken in the form of supplements can lead to hypercalcemia and cause symptoms of anorexia, nausea, and vomiting, frequently followed by polyuria, polydipsia, pruritus, central nervous manifestations of insomnia, depression, nervousness, weakness, and ultimately renal failure (Vieth, 1999).
The B vitamins are water soluble and are present in many foods but can easily become depleted in the context of ED. Poor nutrition leading to vitamin B1 (thiamine) deficiency can occur in AN as with AUD and can lead to life-threatening Wernicke’s encephalopathy and/or Korsakoff’s syndrome in some patients (Handler & Perkin, 1982; McCormick, Buchanan, Onwuameze, Pierson, & Paradiso, 2011; Peters, Parvin, Petersen, Faircloth, & Levine, 2007; Saad, Silva, Banzato, Dantas, & Garcia, 2010; Sharma, Sumich, Francis, Kiernan, & Spira, 2002). Thiamine can be stored in the body for only 9–18 days and is an essential cofactor for glucose to enter the Krebs cycle for energy utilization. The brain and heart require a constant supply of glucose and are prone to severe damage when glucose by-products accumulate in the tissues and cannot be used for energy. Wernicke’s encephalopathy occurs during the acute thiamine-deficient state and can be rapidly fatal especially when glucose is given without pretreatment with thiamine (Watson, Walker, Tomkin, Finn, & Keogh, 1981). The long-term sequela for those who survive thiamine deficiency is Korsakoff’s syndrome. This syndrome is characterized by confabulatory amnesia (dementia), apathy, poor insight, and oculomotor manifestations such as eye-muscle weakness and/or nystagmus. Most cases of Korsakoff’s syndrome occur in the absence of any clear encephalopathic episodes (Ogershok, Rahman, Nestor, & Brick, 2002). Both conditions are under-recognized in the medical setting, especially in the setting of starvation without AUD. One study of AN patients being hospitalized for treatment found that 1/3 were deficient in thiamine (Winston, Jamieson, Madira, Gatward, & Palmer, 2000). Thiamine deficiency is known to cause damage primarily to the thalamus (Zuccoli et al., 2009) even before any neurological signs are present in animals (Langlais & Zhang, 1997). In a sample of 14 patients with AN undergoing longitudinal brain imaging, two subjects had thiamine deficiency (thiamine diphosphate <70 nmol/L) and showed magnetic resonance imaging evidence of significantly increased thalamic volume (McCormick, McCann, & Keel, 2012), suggestive of osmotic damage that occurs in acute Wernicke’s encephalopathy (Jung, Chanraud, & Sullivan, 2012).
Although rare, pellagra from vitamin B3 (niacin) deficiency has been shown to occur in AN and has a characteristic desquamation rash that primarily affects the face and periphery and is worsened with sun exposure (Jagielska, Tomaszewicz-Libudzic, & Brzozowska, 2007; MacDonald & Forsyth, 2005; Prousky, 2003; Rapaport, 1985). Riboflavin and/or biotin deficiency can also occur in AN and AUD and can cause dermatitis that is similar to that in pellagra (Capo-Chichi et al., 1999; Gehrig & Dinulos, 2010; Rock & Vasantharajan, 1995). Similarly, vitamin B6 (pyridoxine) deficiency has been shown to occur with ED or AUD and can cause seborrheic dermatitis as well as peripheral neuropathy (Majumdar, Shaw, O’Gorman, Aps, Offerman, & Thomson, 1982; Schlosser, Pirigyi, & Mirowski, 2011). Folate and vitamin B12 deficiencies have been shown to occur in AN and BN (Eedy, Curran, & Andrews, 1986; Moyano, Vilaseca, Artuch, Valls, & Lambruschini, 1998) and can lead to megaloblastic anemia (Miller et al., 2005; Misra et al., 2004) and cognitive impairment (Katzman, Christensen, Young & Zipursky, 2001; McDowell et al., 2003; Tchanturia et al., 2004). The effects of folate and thiamine deficiency that lead to anemia and cognitive impairment have been well described in elderly patients who sometimes have dietary deficiencies in these vitamins as well (Morris, Jacques, Rosenberg, & Selhub, 2007; Roberts, Martin-Clavijo, Winston, Dharmagunawardena, & Gach, 2007; Selhub, Morris, Jacques, & Rosenberg, 2009). Vitamin E and other antioxidants have also been found to be reduced in some people with AN and are thought to be due to poor nutrition and oxidative stress from starvation (Moyano et al., 1999). Zinc deficiency can occur in AN and AUD, which has been associated with a number of physiological problems, including anorexia (poor appetite), growth retardation, acquired acrodermatitis enteropathica (peripheral and perioral dermatitis), taste disorder, diarrhea, and hypogonadism (Kim et al., 2010; Roberts, Martin-Clavijo, Winston, Dharmagunawardena, & Gach, 2007; Suzuki et al., 2011). Secondary zinc deficiency can occur in the presence of low levels of vitamins A and D (Potocnik et al., 2006). Vitamin K deficiency has been described in a patient with BN and was due to poor intake of green leafy vegetables (Niiya et al., 1983). Several studies have assessed whether iron, vitamin A, or essential fatty acids are deficient in ED and SUD and these appear to be normal in most patients with these conditions (Forbes & Parsons, 2012; Langan & Farrell, 1985; Lieb et al., 2011; Sabel et al., 2013).
Macronutrient deficiency in the presence of calorie restriction in its most severe form causes marasmus and has been seen in children and adults and is still prevalent in countries with poor access to food (Román, 2013). Protein deficiency in the presence of normal calories has been shown to cause Kwashiorkor in AN characterized by severe edema, muscle wasting, enlarged abdomen, thinning hair, loss of teeth, skin depigmentation, dermatitis, and edema (Esca, Brenner, Mach, & Gschnait, 1979; Grillet & Harms, 1980). Hypoglycemia can occur in AN and AUD, especially at very low weight (average BMI of 13) and/or in the presence of liver damage (Gaudiani, Sabel, Mascolo, & Mehler, 2012), which can lead to ketoacidosis, coma, and/or death (Fulop, Ben-Ezra, & Bock, 1986; Rich, Caine, Findling, & Shaker, 1990; Yanai, Yoshida, Tomono, & Tada, 2008). Cardiomyopathy or heart failure can occur in AN and can be due to deficiencies in protein, thiamine, phosphorus, magnesium, selenium, and/or ipecac poisoning (Birmingham & Gritzner, 2007). Some of the behaviors associated with ED can cause exposure to toxins. One such example was reported by one of the authors of this chapter. A 47-year-old woman with a 30-year history of AN who for 7 years had reduced her food intake to almost exclusively canned tuna was hospitalized at 53 % of her expected body weight showing marked depression and confusion and was found to have frank mercury poisoning (Ravneet & Paradiso, 2008).
Some of the complications from nutritional deficiencies do not emerge until refeeding efforts are instituted. For example, in AN it is rare for a person to have phosphate deficiency on admission for hospitalization, but this nutrient can be rapidly depleted and lead to heart failure within a few days of refeeding (O’Connor & Nicholls, 2013). A study of 50 hospitalized AN patients revealed that 60 % of patients had low magnesium and that magnesium levels should also be assessed and replaced when necessary during the first 3 weeks of refeeding (Birmingham, Puddicombe, Hlynsky, 2004). Low magnesium levels can also occur in BN and AUD and exacerbate hypocalcemia and prolong muscle tetany, cardiac arrhythmias, and even heart failure (Abbott, Nadler, & Rude, 1994; Fonseca & Havard, 1985; Hall, Beresford, & Hall, 1989). Similarly, hyponatremia is known to occur in AN and BN (Caregaro, Di Pascoli, Favaro, Nardi, & Santonastaso, 2005) and replacing sodium too quickly can lead to anasarca or refeeding edema (Rigaud, Boulier, Tallonneau, Brindisi, & Rozen, 2010). Rapid correction of hyponatremia in ED and AUD, especially in the context of hypokalemia, can also cause central pontine myelinolysis, which can manifest as acute paralysis and dysphagia (Amann, Schäfer, Sterr, Arnold, & Grunze, 2001; Heng et al., 2007; Malhotra & Ortega, 2013; Patel, Matthews, & Bruce-Jones, 2008). Guidelines on monitoring and supplementation of macro- and micronutrients during early refeeding are discussed in Chap. 23. In addition, many of these nutritional deficiencies can have adverse effects on a developing fetus, and malnutrition in AN and BN and obesity in BED can all lead to reduced fertility (Linna et al., 2013).
4 Co-occurrence of SUD and ED May Increase the Incidence of Malnutrition
SUD and ED have a high rate of co-occurrence (Bulik et al., 2004; Lilenfeld et al., 1998), especially between AUD and ED with bulimic features (Baker, Mitchell, Neale, & Kendler, 2010; Duncan et al., 2006; Hudson, Hiripi, Pope, & Kessler, 2007; Munn-Chernoff et al., 2013; Slane, Burt, & Klump, 2012). A meta-analysis of 21 studies reported a median rate of 23.0 % of alcohol use among individuals with BN (Holderness, Brooks-Gunn, & Warren, 1994). Another study found an AUD rate of 21 % in people with AN, most of which developed AN prior to an AUD (Baker et al., 2010). While the majority of people with AN do not develop AUD, when it does occur, there is a significantly increased risk of death and thus it is recommended that clinicians inquire about alcohol use in this population (Bulik et al., 2004). Alternatively, in a study of 140 people with SUD without organic pathology, compared to 50 healthy adults, over 90 % weighed under the mean weight for the population and over half had experienced weight loss and reduced appetite, while nearly 20 % met criteria for severe malnutrition (Santolaria-Fernández et al., 1995). While there are no studies that have specifically assessed increased risk of malnutrition when ED and SUD co-occur, it is likely that there is an increased risk of malnutrition, electrolyte abnormalities, and/or vitamin and mineral deficiencies due to poor intake, absorption, and utilization of essential nutrients. More research in this area is greatly needed.
Conclusions
ED and SUD can lead to unhealthy eating and malnutrition that is associated with varying degrees of medical morbidity and increased risk of death. These disorders likely share some aspects of underlying pathophysiology related to reward processing in the brain as well as common medical sequelae due to nutritional deficits. Vitamin and mineral deficiencies are most common in patients with AN, BN, and AUD but can be seen in other SUD as well. The most widely appreciated nutritional deficiency is for B vitamins, particularly thiamine in AUD, but several research studies have shown that this occurs in AN as well and can cause severe neurological sequelae and/or death. More research is needed to fully understand the neurobiological consequences of malnutrition in SUD and ED and to determine the extent of the additive effects when these conditions co-occur.
References
Abbott, L., Nadler, J., & Rude, R. K. (1994). Magnesium deficiency in alcoholism: Possible contribution to osteoporosis and cardiovascular disease in alcoholics. Alcoholism: Clinical and Experimental Research, 18, 1076–1082.
Abd El Gawad, S., Hassan, S., Ghanem, A., Awad, M., & Ali, A. (2011). Effects of drug addiction on antioxidant vitamins and nitric oxide levels. Journal of Basic Applied Scientific Research, 1, 485–491.
Aggrawal, A. (2001). Narcotic drugs. New Delhi, India: National Book Trust.
Aksenov, M. Y., Aksenov, M. V., Nath, A., Ray, P., Mactutus, C., & Booze, R. (2006). Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures. The role of oxidative stress and D1 dopamine receptors. Neurotoxicology, 27, 217–228.
Amann, B., Schäfer, M., Sterr, A., Arnold, S., & Grunze, H. (2001). Central pontine myelinolysis in a patient with anorexia nervosa. International Journal of Eating Disorders, 30, 462–466.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: Author.
Anglin, M., Burke, C., Perrochet, B., Stamper, E., & Dawud-Noursi, S. (2000). The CSAT methamphetamine treatment project. Moving research into the real world. Journal of Psychoactive Drugs, 32, 137–141.
Ares-Santos, S., Granado, N., & Moratalla, R. (2013). The role of dopamine receptors in the neurotoxicity of methamphetamine. Journal of Internal Medicine, 273, 437–453.
Baker, J. H., Mitchell, K. S., Neale, M. C., & Kendler, K. (2010). Eating disorder symptomatology and substance use disorders, prevalence and shared risk in a population based twin sample. International Journal of Eating Disorders, 43, 648–658.
Beharry, M. S. (2012). Health issues in the homeless youth population. Pediatric Annals, 41, 154–156.
Birmingham, C. L., Puddicombe, D., & Hlynsky, J. (2004). Hypomagnesemia during refeeding in anorexia nervosa. Eating and Weight Disorders, 9(3), 236–237.
Birmingham, C. L., & Gritzner, S. (2007). Heart failure in anorexia nervosa: Case report and review of the literature. Eating and Weight Disorders, 12, e7–e10.
Bulik, C., Klump, K., Thornton, L., Kaplan, A., Devlin, B., Fichter, M., … Kaye, W. (2004). Alcohol comorbidity in eating disorders. A multicenter study. Journal of Clinical Psychiatry, 65, 1000–1006.
Cairney, S., O’Connor, N., Dingwall, K. M., Maruff, P., Shafiq-Antonacci, R., Currie, J., & Currie, B. (2013). A prospective study of neurocognitive changes 15 years after chronic inhalant abuse. Addiction, 108, 1107–1114.
Capela, J., daCosta, A., Costa, V., Ruscher, K., Fernandes, E., Bastos, M., … Carvalho, F. (2013). The neurotoxicity of hallucinogenic amphetamines in primary cultures of hippocampal neurons. Neurotoxicology, 34, 254–263.
Capo-chichi, C., Guéant, J., Lefebvre, E., Bennani. N., Lorentz, E., Vidailhet, C., & Vidailhet, M. (1999). Riboflavin and riboflavin-derived cofactors in adolescent girls with anorexia nervosa. American Journal of Clinical Nutrition, 69, 672–678.
Caregaro, L., Di Pascoli, L., Favaro, A., Nardi, M., & Santonastaso, P. (2005). Sodium depletion and hemoconcentration: Overlooked complications in patients with anorexia nervosa? Nutrition, 21, 438–445.
Casper, R., Kirschner, B., Sandstead, H., Jacob, R., & Davis, J. (1980). An evaluation of trace metals, vitamins and taste function in anorexia nervosa. American Journal of Clinical Nutrition, 33, 1801–1808.
Clugston, R. D., & Blaner, W. S. (2012). The adverse effects of alcohol on vitamin A metabolism. Nutrients, 4, 356–371.
Coppen, A. (2005). Treatment of depression: Time to consider folic acid and vitamin B12. Journal of Psychopharmacology, 19, 59–65.
Cowan, R. L., Roberts, D. M., & Joers, J. (2008). Neuroimaging in human MDMA (Ecstasy) users. Annals of the New York Academy of Sciences, 1139, 291–298.
Davenport-Hines, R. (2003). The pursuit of oblivion: A global history of narcotics. New York, NY: W.W. Norton.
Davis, C., Levitan, R., Kaplan, A., Carter, J., Reid, C., Curtis, C., … Kennedy, J. (2007). Dopamine transporter (DAT1) gene associated with appetite suppression to methylphenidate in a case-control study of binge eating disorder. Neuropsychopharmacology, 22, 2199–2206.
De Caprio, C., Alfano, A., Senatore, I., Zarrella, L., Pasanisi, F., & Contaldo, F. (2006). Severe acute liver damage in anorexia nervosa: Two case reports. Nutrition, 22, 572–575.
Devgun, M. S., Fiabane, A., Paterson, C. R., Zarembski, P., & Guthrie, A. (1981). Vitamin and mineral nutrition in chronic alcoholics including patients with Korsakoff’s psychosis. British Journal of Nutrition, 45, 469–473.
Duncan, A. E., Neuman, R. J., Kramer, J. R., Kuperman, S., Hesselbrock, V. M., & Bucholz, K. K. (2006). Lifetime psychiatric comorbidity of alcohol dependence and bulimia nervosa in women. Drug and Alcohol Dependence, 84, 122–132.
Eedy, D. J., Curran, J. G., & Andrews, W. (1986). A patient with bulimia nervosa and profound folate deficiency. Postgraduate Medical Journal, 62, 853–854.
el-Nakah, A., Frank, O., Louria, D., Quinones, M., & Baker, H. (1979). A vitamin profile of heroin addiction. American Journal of Public Health, 69, 1058–1060.
Esca, S. A., Brenner, W., Mach, K., & Gschnait, F. (1979). Kwashiorkor-like zinc deficiency syndrome in anorexia nervosa. Acta Dermato Venereologica, 59(4), 361–364.
Fonseca, V. A., D’Souza, V., Houlder, S., Thomas, M., Wakeling, A., & Dandona, P. (1988). Vitamin D deficiency and low osteocalcin concentrations in anorexia nervosa. Journal of Clinical Pathology, 41, 195–197.
Fonseca, V., & Havard, C. W. (1985). Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa. British Medical Journal (Clinical Research Edition), 291, 1680–1682.
Forbes, D., & Parsons, H. (2012). Essential fatty acids: Food for mind and body. Acta Paediatrica, 101, 808–810.
Fulop, M., Ben-Ezra, J., & Bock, J. (1986). Alcoholic ketosis. Alcoholism Clinical and Experimental Research, 10, 610–615.
Galasko, G. (1997). Cocaine, a risk factor for myocardial infarction. European Journal of Preventive Medicine & Cardiology, 4, 185–190.
Gaudiani, J. L., Sabel, A. L., Mascolo, M., & Mehler, P. S. (2012). Severe anorexia nervosa: Outcomes from a medical stabilization unit. International Journal of Eating Disorders, 45, 85–92.
Gehrig, K. A., & Dinulos, J. G. (2010). Acrodermatitis due to nutritional deficiency. Current Opinion in Pediatrics, 22, 107–112.
Glick, J. (1990). Dementias: The role of magnesium deficiency and a hypothesis concerning the pathogenesis of Alzheimer’s disease. Medical Hypotheses, 31, 211–225.
Goebels, N., & Soyka, M. (2000). Dementia associated with B12 vitamin deficiency: Presentation of 2 cases and a review of literature. Journal of Neuropsychiatry Clinical Neuroscience, 12, 389–394.
González-Reimers, E., Alvisa-Negrín, J., Santolaria-Fernández, F., Martín-González, C. M., Hernández-Betancor, I., Fernández-Rodríguez, C. M., … González-Díaz, A. (2011). Vitamin D and nutritional status are related to bone fractures in alcoholics. Alcohol, 46, 148–155.
Grillet, J. P., & Harms, M. (1980). Kwashiorkor and zinc deficiency in an adult with anorexia nervosa. Annales de Dermatologie et de Venereologie, 107, 187–191.
Gueguen, S., Pirollet, P., Leroy, P., Guilland, J., Arnuad, J., Paille, J., … Herbeth, B. (2003). Changes in serum retinol, alpha-tocopherol, vitamin C, carotenoid, zinc and selenium after micronutrient supplementation during alcohol rehabilitation. Journal of American College of Nutrition, 22, 303–310.
Hall, R. C., Beresford, T. P., & Hall, A. K. (1989). Hypomagnesemia in eating disorder patients: Clinical signs and symptoms. Psychiatric Medicine, 7, 193–203.
Handler, C. E., & Perkin, G. D. (1982). Anorexia nervosa and Wernicke’s encephalopathy: An underdiagnosed association. Lancet, 2, 771–772.
Heng, A. E., Vacher, P., Aublet-Cuvelier, B., Garcier, J. M., Sapin, V., Deteix, P., & Souweine, B. (2007). Centropontine myelinolysis after correction of hyponatremia: Role of associated hypokalemia. Clinical Nephrology, 67, 345–351.
Hofland, S. L., & Dardis, P. O. (1992). Bulimia nervosa. Associated physical problems. Journal of Psychosocial Nursing and Mental Health Services, 30, 23–27.
Holderness, C., Brooks-Gunn, J., & Warren, M. (1994). Co-morbidity of eating disorders and substance abuse review of literature. International Journal of Eating Disorders, 16, 1–34.
Hudson, J. I., Hiripi, E., Pope, H. G., Jr., & Kessler, R. C. (2007). The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biological Psychiatry, 61, 348–358.
Iber, F. L., Shamszad, M., Miller, P. A., & Jacob, R. (1986). Vitamin K deficiency in chronic alcoholic males. Alcoholism Clinical and Experimental Research, 10, 679–681.
Islam, S., Hossain, K., Ahmed, A., & Ahsan, M. (2002). Nutritional status of drug addicts undergoing detoxification: Prevalence of malnutrition and influence of illicit drugs and lifestyle. British Journal of Nutrition, 88, 507–513.
Isner, J., Estes, M., Thompson, P., Constanzo-Nordin, M., Subramanian, R., Miller, G., … Sturner, W. (1986). Acute cardiac events temporally related to cocaine abuse. New England Journal of Medicine, 315, 1438–1443.
Jagielska, G., Tomaszewicz-Libudzic, E. C., & Brzozowska, A. (2007). Pellagra: A rare complication of anorexia nervosa. European Child and Adolescent Psychiatry, 16, 417–420.
Johnson, T. P., Freels, S. A., Parsons, J. A., & Vangeest, J. B. (1997). Substance abuse and homelessness: Social selection or social adaptation? Addiction, 92, 437–445.
Jung, Y. C., Chanraud, S., & Sullivan, E. V. (2012). Neuroimaging of Wernicke’s encephalopathy and Korsakoff’s syndrome. Neuropsychology Review, 22, 170–180.
Katz, N., & Norman, M. (2009). The impact of opioids on the endocrine system. Clinical Journal of Pain, 25, 170–175.
Katzman, D., Christensen, B., Young, A., & Zipursky, R. (2001). Starving the brain: Structural abnormalities and cognitive impairment in adolescents with anorexia nervosa. Seminars in Clinical Neuropsychiatry, 6, 146–152.
Kim, S. T., Kang, J. S., Baek, J. W., Kim, T. K., Lee, J. W., Jeon, Y. S., & Suh, K. S. (2010). Acrodermatitis enteropathica with anorexia nervosa. Journal of Dermatology, 37, 726–729.
Krikorian, A. (1975). Were the opium poppy and opium known in the ancient near East? Journal of the History of Biology, 8, 95–114.
Langan, S. M., & Farrell, P. M. (1985). Vitamin E, vitamin A and essential fatty acid status of patients hospitalized for anorexia nervosa. American Journal of Clinical Nutrition, 41, 1054–1060.
Lange, R., & Hillis, D. (2001). Cardiovascular complications of cocaine abuse. New England Journal of Medicine, 345, 351–358.
Langlais, P. J., & Zhang, S. X. (1997). Cortical and subcortical white matter damage without Wernicke’s encephalopathy after recovery from thiamine deficiency in the rat. Alcoholism Clinical and Experimental Research, 21, 434–443.
Le Strat, Y., & Le Foll, B. (2011). Obesity and cannabis use: Results from 2 representative national surveys. American Journal of Epidemiology, 174, 929–933.
Legroux-Gerot, I., Vignau, J., Collier, F., & Cortet, B. (2005). Bone loss associated with anorexia nervosa. Joint Bone Spine, 72, 489–495.
Lieb, M., Palm, U., Hock, B., Schwarz, M., Domke, I., & Soyka, M. (2011). Effects of alcohol consumption on iron metabolism. American Journal of Drug and Alcohol Abuse, 37, 68–73.
Lieber, C. (2003). Relationships between nutrition, alcohol use and liver disease. Alcohol Research and Health, 27, 227–231.
Lilenfeld, L., Kaye, W., Greeno, C., Merikangas, K., Plotnicov, K., Pollice, C., … Nagy, L. (1998). A controlled family study of anorexia nervosa and bulimia nervosa. Archives of General Psychiatry, 55, 603–610.
Linna, M. S., Raevuori, A., Haukka, J., Suvisaari, J. M., Suokas, J. T., & Gissler, M. (2013). Reproductive health outcomes in eating disorders. International Journal of Eating Disorders. Advance online publication. doi:10.1002/eat.22179
Lough, M. E. (2012). Wernicke’s encephalopathy: Expanding the diagnostic toolbox. Neuropsychology Review, 22, 181–194.
MacDonald, A., & Forsyth, A. (2005). Nutritional deficiencies and the skin. Clinical and Experimental Dermatology, 30, 388–390.
Maesaka, A., & Hasegawa, Y. (2003). Osteoporosis in anorexia nervosa. Clinical Calcium, 13, 1570–1576.
Majumdar, S. K., Shaw, G. K., O’Gorman, P., Aps, E. J., Offerman, E. L., & Thomson, A. D. (1982). Blood vitamin status (B1, B2, B6, folic acid and B12) in patients with alcoholic liver disease. International Journal for Vitamin and Nutrition Research, 52, 266–271.
Malhotra, K., & Ortega, L. (2013). Central pontine myelinolysis with meticulous correction of hyponatraemia in chronic alcoholics. British Medical Journal Case Reports. doi:10.1136/bcr-2013-009970.
Marona-Lewicka, D., Nichols, C. D., & Nichols, D. E. (2011). An animal model of schizophrenia based on chronic LSD administration: Old idea, new results. Neuropharmacology, 6, 503–512.
McClain, C., Barve, S., Barve, A., & Marsano, L. (2011). Alcoholic liver disease and malnutrition. Alcoholism Clinical and Experimental Research, 35, 815–820.
McCormick, L. M., Buchanan, J. R., Onwuameze, O. E., Pierson, R. K., & Paradiso, S. (2011). Beyond alcoholism: Wernicke-Korsakoff syndrome in patients with psychiatric disorders. Cognitive and Behavioral Neurology, 24(4), 209–216.
McCormick, L. M., McCann, E., & Keel, P. K. (2012, September). Thiamine deficiency in anorexia nervosa. Poster presentation at the Eating Disorder Research Society Meeting, Porto, Portugal.
McDowell, B., Moser, D., Ferneyhough, K., Bowers, W., Andersen, A., & Paulsen, J. (2003). Cognitive impairment in anorexia nervosa is not due to depressed mood. International Journal of Eating Disorders, 33, 351–355.
Meleger, A. L., Froude, C. K., & Walker, J., III. (2013). Nutrition and eating behavior in a sample of patients with chronic pain on long-term opioid therapy. Physical Medicine and Rehabilitation. Advance online publication. doi:10.1016/j.pmrj.2013.08.597
Miller, K., Grinspoon, S., Ciampa, J., Hier, J., Herzog, D., & Klibanski, A. (2005). Medical findings in outpatients with anorexia nervosa. Journal of American Medical Association, 165, 561–566.
Misra, M., Aggarwal, A., Miller, K., Almazan, C., Worley, M., Soyka, L., … Klibanski, A. (2004). Effects of anorexia nervosa on clinical, hematological, biochemical and bone density parameters in community-dwelling adolescent girls. Pediatrics, 114, 1574–1583.
Mohs, M., Watson, R., & Leonard-Green, T. (1990). Nutritional effects of marijuana, heroin, cocaine and nicotine. Journal of American Dietetic Association, 90, 1261–1267.
Morabia, A., Fabre, J., Ghee, E., Zeger, Z., Orsat, E., & Robert, A. (1989). Diet and opiate addiction: A quantitative assessment of the diet of non-institutionalized opiate addicts. British Journal of Addiction, 84, 173–180.
Morris, M., Jacques, P., Rosenberg, I., & Selhub, J. (2007). Folate and vitamin B12 in relation to anemia, macrocytosis and cognitive impairment in older Americans in the age of folic acid fortification. American Journal of Clinical Nutrition, 85, 193–200.
Moyano, D., Sierra, C., Brandi, N., Artuch, R., Mira, A., García-Tornel, S., & Vilaseca, M. A. (1999). Antioxidant status in anorexia nervosa. International Journal of Eating Disorders, 25, 99–103.
Moyano, D., Vilaseca, M. A., Artuch, R., Valls, C., & Lambruschini, N. (1998). Plasma total-homocysteine in anorexia nervosa. European Journal of Clinical Nutrition, 52, 172–175.
Munn-Chernoff, M. A., Duncan, A. E., Grant, J. D., Wade., T. D., Agrawal, A., Bucholz, K. K., … Heath, A. C. (2013). A twin study of alcohol dependence, binge eating, and compensatory behaviors. Journal of Studies in Alcohol and Drugs, 74, 664–673.
Neale, J., Nettleton, S., Pickering, L., & Fischer, J. (2012). Eating patterns among heroin users: A qualitative study with implications for nutritional interventions. Addiction, 107, 635–641.
Niiya, K., Kitagawa, T., Fujishita, M., Yoshimoto, S., Kobayashi, M., Kubonishi, I., … Miyoshi, I. (1983). Bulimia nervosa complicated by deficiency of vitamin K-dependent coagulation factors. Journal of American Medical Association, 250, 792–703.
O’Connor, G., & Nicholls, D. (2013). Refeeding hypophosphatemia in adolescents with anorexia nervosa: A systematic review. Nutrition in Clinical Practice, 28, 358–364.
Ogershok, P. R., Rahman, A., Nestor, S., & Brick, J. (2002). Wernicke encephalopathy in nonalcoholic patients. American Journal of Medical Sciences, 323, 107–111.
Olsen, G. D. (1995). Potential mechanisms of cocaine-induced developmental neurotoxicity: A minireview. Neurotoxicology, 16(1), 159–167. Review.
Patel, A. S., Matthews, L., & Bruce-Jones, W. (2008). Central pontine myelinolysis as a complication of refeeding syndrome in a patient with anorexia nervosa. Journal of Neuropsychiatry Clinical Neuroscience, 20, 371–373.
Penner, E. A., Buettner, H., & Mittleman, M. A. (2013). The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. American Journal of Medicine, 126, 583–589.
Perkonigg, A., Lieb, R., & Wittchen, H. U. (1998). Prevalence of use, abuse and dependence of illicit drugs among adolescents and young adults in a community sample. European Addiction Research, 4, 58–66.
Peters, T. E., Parvin, M., Petersen, C., Faircloth, V. C., & Levine, R. L. (2007). A case report of Wernicke’s encephalopathy in a pediatric patient with anorexia nervosa – Restricting type. Journal of Adolescent Health, 40, 376–383.
Potocnik, F. C., van Rensburg, S. J., Hon, D., Emsley, R. A., Moodie, I. M., & Erasmus, R. T. (2006). Oral zinc augmentation with vitamins A and D increases plasma zinc concentration: Implications for burden of disease. Metabolic Brain Disease, 21, 139–147.
Prousky, J. E. (2003). Pellagra may be a rare secondary complication of anorexia nervosa: A systematic review of the literature. Alternative Medicine Review, 8, 180–185.
Ramsey, D., & Muskin, P. R. (2013). Available online at: http://www.currentpsychiatry.com/home/article/vitamin-deficiencies-and-mental-health-how-are-they-linked/db4fbfd1534c62b9e1a9d7dcf6dc311e.html
Rapaport, M. J. (1985). Pellagra in a patient with anorexia nervosa. Archives of Dermatology, 121, 255–257.
Rasmussen, H., Mortensen, P., & Jensen, I. (1989). Depression and magnesium deficiency. International Journal of Psychiatry in Medicine, 19, 57–63.
Ravneet, D., & Paradiso, S. (2008). Anorexia nervosa and mercury toxicity. The American Journal of Psychiatry, 165(11), 1489.
Raymond, N. C., Bartholome, L. T., Lee, S. S., Peterson, R. E., & Raatz, S. K. (2007). A comparison of energy intake and food selection during laboratory binge eating episodes in obese women with and without a binge eating disorder diagnosis. International Journal of Eating Disorders, 40, 67–71.
Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009). Global burden of disease and injury and economic costs attributable to alcohol use and alcohol use disorders. Lancet, 373, 2223–2233.
Rich, L. M., Caine, M. R., Findling, J. W., & Shaker, J. L. (1990). Hypoglycemic coma in anorexia nervosa. Case report and review of the literature. Archives of Internal Medicine, 150, 894–895.
Rigaud, D., Boulier, A., Tallonneau, I., Brindisi, M. C., & Rozen, R. (2010). Body fluid retention and body weight change in anorexia nervosa patients during refeeding. Clinical Nutrition, 29, 749–755.
Roberts, L., Finch, P., Pullan, P., Bhagat, C., & Price, L. (2002). Sex hormone suppression by intrathecal opioids: A prospective study. Clinical Journal of Pain, 18, 144–148.
Roberts, C. M., Martin-Clavijo, A., Winston, A. P., Dharmagunawardena, B., & Gach, J. E. (2007). Malnutrition and a rash: Think zinc. Clinical and Experimental Dermatology, 32, 654–657.
Rock, C. L., & Vasantharajan, S. (1995). Vitamin status of eating disorder patients: Relationship to clinical indices and effect of treatment. International Journal of Eating Disorders, 18, 257–262.
Rodondi, N., Pletcher, M., Liu, K., Hulley, S., & Sidney, S. (2006). Marijuana use, diet, body mass index and cardiovascular risk factors (from the CARDIA study). American Journal of Cardiology, 98, 478–484.
Román, G. C. (2013). Nutritional disorders in tropical neurology. Handbook of Clinical Neurology, 114, 381–404.
Saad, L., Silva, L. F., Banzato, C. E., Dantas, C. R., & Garcia, C., Jr. (2010). Anorexia nervosa and Wernicke-Korsakoff syndrome: A case report. Journal of Medical Case Reports, 4, 217.
Sabel, A. L., Gaudiani, J. L., Statland, B., & Mehler, P. S. (2013). Hematological abnormalities in severe anorexia nervosa. Annals of Hematology, 92, 605–613.
Saeland, M., Haugen, M., Eriksen, F., Smehaugen, A., Wandel, M., Bohmer, T., & Oshaug, A. (2008). Living as a drug addict in Oslo, Norway – A study focusing on nutrition and health. Public Health Nutrition, 12, 630–636.
Sanchis-Segura, C., & Spanagel, R. (2006). Behavioural assessment of drug reinforcement and addictive features in rodents: An overview. Addiction Biology, 11, 2–38.
Santolaria-Fernández, F. J., Gómez-Sirvent, J. L., González-Reimers, C. E., Batista-López, J. N., Jorge-Hernández, J. A., Rodríguez-Moreno, F., … Hernández-García, M. T. (1995). Nutritional assessment of drug addicts. Drug and Alcohol Dependence, 38, 11–18.
Schachter, H., King, J., Langford, S., & Moher, D. (2001). How efficacious and safe is long-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165, 1475–1488.
Schlosser, B. J., Pirigyi, M., & Mirowski, G. W. (2011). Oral manifestations of hematologic and nutritional diseases. Otolaryngological Clinics of North America, 44, 183–203.
Schneider, M. (2003). Bulimia nervosa and binge-eating disorder in adolescents. Adolescent Medicine, 14, 119–131.
Scott, J. M., & Molloy, A. M. (2012). The discovery of vitamin B(12). Annals of Nutrition and Metabolism, 61, 239–245.
Selhub, J., Morris, M., Jacques, P., & Rosenberg, I. (2009). Folate-vitamin B12 interaction in relation to cognitive impairment, anemia and indicators of vitamin B12 deficiency. American Journal of Clinical Nutrition, 89, 702S–706S.
Setnick, J. (2010). Micronutrient deficiency and supplementation in anorexia nervosa and bulimia nervosa: A review of literature. Nutrition in Clinical Practice, 25, 137–142.
Sharma, S., Sumich, P. M., Francis, I. C., Kiernan, M. C., & Spira, P. J. (2002). Wernicke’s encephalopathy presenting with upbeating nystagmus. Journal of Clinical Neuroscience, 9, 476–478.
Simopoulos, A. P. (2001). The Hippocratic concept of positive health in the 5th Century BC and in the New Millennium. In A. P. Simopoulos & K. N. Pavlou (Eds.), Nutrition and fitness: Metabolic studies in health and disease (World review of nutrition and dietetics, Vol. 90, pp. 1–4). Basel, Switzerland: Karger.
Slane, J. D., Burt, S. A., & Klump, K. L. (2012). Bulimic behaviors and alcohol use: Shared genetic influences. Behavior Genetics, 42, 603–613.
Smit, E., & Crespo, C. (2001). Dietary intake and nutritional status of US adult marijuana users: Results from the 3rd National Health and Nutritional Examination Survey. Public Health Nutrition, 4, 781–786.
Strohle, A., Wolters, M., & Hahn, A. (2012). Alcohol intake-a-two-edged sword. Part 1: Metabolic and pathogenic effects of alcohol. Medizinische Monatsschrift Pharmazeuten, 35, 281–292.
Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality. (2011). The TEDS Report: Characteristics of probation and parole admissions aged 18 or older. Rockville, MD: Author.
Suzuki, H., Asakawa, A., Li, J. B., Tsai, M., Amitani, H., Ohinata, K., … Inui, A. (2011). Zinc as an appetite stimulator – The possible role of zinc in the progression of diseases such as cachexia and sarcopenia. Recent Patents on Food, Nutrition and Agriculture, 3, 226–231.
Takagi, M., Lubman, D., & Yucel, M. (2011). Solvent-induced leukoencephalopathy: A disorder of adolescence? Substance Use & Misuse, 46, 95–98.
Tchanturia K., Anderluh, M., Morris, R., Rabe-Hesketh, S., Collier, D., Sanchez, P., & Treasure, J. (2004). Cognitive flexibility in anorexia nervosa and bulimia nervosa. Journal of the International Neuropsychological Society, 10, 513–520.
Tiemeier, H., Tuijl, R., Hofman, A., Meijer, J., Kiliaan, A., & Breteler, M. (2002). Vitamin B12, folate and homocysteine in depression. The Rotterdam study. American Journal of Psychiatry, 159, 2099–2101.
Tomita, K., Haga, H., Ishii, G., Katsumi, T., Sato, C., Aso, R., … Ueno, Y. (2013). Clinical manifestations of liver injury in patients with anorexia nervosa. Hepatology Research. Advance online publication. doi: 10.1111/hepr.12202
Vieth, R. (1999). Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. American Journal of Clinical Nutrition, 69, 842–856.
Walsh, S., Donny, E., Nuzzo, P., Umbricht, A., & Bigelow, G. (2010). Cocaine abuse versus dependence: Cocaine self-administration and pharmacodynamics response in the human laboratory. Drug and Alcohol Dependence, 106, 28–37.
Watson, A. J., Walker, J. F., Tomkin, G. H., Finn, M. M., & Keogh, J. A. (1981). Acute Wernickes encephalopathy precipitated by glucose loading. Irish Journal of Medical Sciences, 150, 301–303.
Winston, A. P., Jamieson, C. P., Madira, W., Gatward, N. M., & Palmer, R. L. (2000). Prevalence of thiamine deficiency in anorexia nervosa. International Journal of Eating Disorders, 28, 451–454.
Winston, A. P. (2012). The clinical biochemistry of anorexia nervosa. Annals of Clinical Biochemistry, 49, 132–143.
Yanai, H., Yoshida, H., Tomono, Y., & Tada, N. (2008). Severe hypoglycemia in a patient with anorexia nervosa. Eating and Weight Disorders, 13, e1–e3.
Zuccoli, G., Santa Cruz, D., Bertolini, M., Rovira, A., Gallucci, M., Carollo, C., & Pipitone, N. (2009). MR imaging findings in 56 patients with Wernicke encephalopathy: Nonalcoholics may differ from alcoholics. American Journal of Neuroradiology, 30, 171–176.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
McCormick, L.M., Onwuameze, O.E., Paradiso, S. (2014). Nutritional Aspects of Eating Disorders, Addictions, and Substance Use Disorders. In: Brewerton, T., Baker Dennis, A. (eds) Eating Disorders, Addictions and Substance Use Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45378-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-45378-6_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45377-9
Online ISBN: 978-3-642-45378-6
eBook Packages: MedicineMedicine (R0)